论文部分内容阅读
目的 :通过对患肺炎新生儿进行临床治疗验证沐舒坦雾化吸入联合静脉注射治疗方式的效果。方法 :统计本院在2014年12月至2016年5月期间收治的新生儿肺炎患儿共计76例进行临床分析,将76例患儿随机平均分成两个组,每组患儿例数为38例。在保证两组无统计学差异的前提下采取不同的治疗方式,一组行沐舒坦静脉滴注治疗,另一组在行沐舒坦静脉滴注的同时辅以雾化吸入治疗,而后对治疗效果进行对比。结果 :在经过同时间治疗之后,对照组38例患儿中有16例显效、16例有效、6例无效,总有效率为84.21%。而观察组38例患儿中有22例显效、14例有效、2例无效,总有效率为94.74%。两组患儿之间的总有效率经过单因子协方差检验结果得出P值小于0.05,差异具有统计学意义。结论 :对于新生儿肺炎的临床治疗,采用单一的沐舒坦静脉滴注具有良好的治疗效果,但相比之下,在行沐舒坦静脉滴注的同时联合行沐舒坦雾化吸入治疗具有更大的疗效优势,具有临床推广应用价值。
Objective: To validate the effect of mucosolvan inhalation combined with intravenous injection on the clinical treatment of neonates with pneumonia. Methods: A total of 76 neonates with pneumonia were admitted to our hospital from December 2014 to May 2016 to conduct a clinical analysis. 76 children were randomly divided into two groups, with a mean of 38 example. In the two groups to ensure that no significant difference under the premise of taking a different treatment, a group of lines of mucosolvan intravenous infusion, the other in the line of mucosolvan intravenous infusion supplemented by atomization inhalation, and then the treatment effect comparing. Results: After the same period of treatment, 16 of the 38 children in the control group were effective, 16 were effective, 6 were ineffective, and the total effective rate was 84.21%. In the observation group, 38 cases were markedly effective in 22 cases, 14 cases were effective, 2 cases were ineffective, the total effective rate was 94.74%. The total effective rate between the two groups of children after single factor covariance test results obtained P value of less than 0.05, the difference was statistically significant. CONCLUSIONS: The clinical treatment of neonatal pneumonia with a single mucosolvan intravenous infusion has a good therapeutic effect, but in contrast, mucosolvan intravenous infusion combined with mucosolvan inhalation has a greater Therapeutic advantages, with clinical application value.